November 3, 2022 — Hologic, Inc., a global leader in women’s health, announced that its 3Dimensions mammography system was awarded EUREF Type Test certification by the European Reference Organisation for Quality Assured Breast Screening and Diagnostic Services (

November 3, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare information technology, announces the introduction of new digital radiography (DR) solutions that will continue to transform the clinical value of X-ray.

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients, announced today that it is developing the MEVION S250-FIT Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS).

The industry is seeing a sense of momentum from industry leaders to help expand lung screening programs

The pace of new lung cancer screening initiatives, published research and collective efforts of organizations and imaging specialists in the United States and across the world has, impressively, quickened. While Lung Cancer Awareness Month is officially on the calendar in November, the work of a broad, committed range of focused experts is a daily priority.
The FDA’s outlined framework and action plan are steps in the right direction, but we need to ensure that inaction or delayed response in addressing regulation of AI and ML do not stall innovation

After lagging other sectors for years, the era of artificial intelligence (AI) in healthcare is dawning as its use is becoming more prevalent in a variety of applications — from medical imaging and ophthalmology, to remote monitoring and leveraging electronic health records (EHRs) to identify potential risk for chronic diseases or complications.

Jenny Dunkley, Director of CVIT Product Marketing, GE Healthcare

Submitted by mtaschetta-millane on Wed, 11/02/2022 - 17:45

November 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced results from its Phase 3 SPOTLIGHT trial that evaluated the impact of various clinical factors

November 2, 2022 — At the Radiological Society of North America’s 2022 annual meeting (RSNA), international medical imaging and cybersecurity company Sectr

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now